Aptamer Group deserve more attention Aptamer Group (LSE: APTA) are unchanged at 0.325p with a £11.7m mkt cap after reporting finals to June 2026 showing…
Aptamer Group reports 27% revenue increase in first half Aptamer Group reports 27% revenue increase in first half…
Aptamer Group secures contract with major pharma AIM-listed Aptamer Group developer announces £360,000 deal with top-tier pharmaceutical company alongside strong commercial momentum. Aptamer Group shares jumped on…
Aptamer Group shares jump on revenue growth and strong order book Aptamer Group plc, the AIM-listed developer of Optimer® binders for life sciences innovation, has revealed a significant upturn in sales…